Optomed Plc: Interim Report, January – March 2021
Optomed Plc Stock Exchange Release 6 May 2021 at 9:00, Helsinki Optomed Plc: Interim Report, January – March 2021 January – March 2021 · Revenue increased by 30.0 percent to EUR 3,944 (3,034) thousand. At comparable exchange rates, revenue grew by 30.4% · Devices segment revenue increased by 48.6 % to EUR 1,447 (974) thousand. At comparable exchange rates, the segment revenue grew by 49.9% · Software segment revenue increased by 21.2 % to EUR 2,497 (2,060) thousand · EBITDA amounted to EUR –315 (-575) thousand corresponding to –8.0 (-19.0) percent of